sr 95531 has been researched along with edetic acid in 1 studies
Studies (sr 95531) | Trials (sr 95531) | Recent Studies (post-2010) (sr 95531) | Studies (edetic acid) | Trials (edetic acid) | Recent Studies (post-2010) (edetic acid) |
---|---|---|---|---|---|
610 | 0 | 209 | 27,553 | 629 | 3,970 |
Protein | Taxonomy | sr 95531 (IC50) | edetic acid (IC50) |
---|---|---|---|
Amyloid-beta precursor protein | Homo sapiens (human) | 7.7 | |
Beta-lactamase VIM-1 | Pseudomonas aeruginosa | 9.3 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Browning, MD; Dunwiddie, TV; Hahner, LD; Harris, RA; Leidenheimer, NJ | 1 |
1 other study(ies) available for sr 95531 and edetic acid
Article | Year |
---|---|
Phosphorylation-independent effects of second messenger system modulators on gamma-aminobutyric acidA receptor complex function.
Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Animals; Chlorides; Colforsin; Cyclic AMP; Edetic Acid; Isoquinolines; Mice; Mice, Inbred ICR; Muscimol; Phosphorylation; Piperazines; Protein Kinases; Pyridazines; Receptors, GABA-A; Second Messenger Systems | 1990 |